Metraipolis › archive › dc_dc248e81cf30

Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis — Europe PMC PMID:41717337

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41717337
DOI
10.1002/jgh3.70365
License (as archived)
solo-consultazione
Archived
2026-11-05T17:49:49.537Z
SHA-256 of the archived text
a329043f5c5b40ca1298e2b92322ec967a24e37fde4c1b8d18e5fb107ec6ea42
Stable URL of this page
https://metraipolis.com/documento/dc_dc248e81cf30

How to cite

Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis — Europe PMC PMID:41717337 — Europe PMC (en), https://europepmc.org/article/MED/41717337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc248e81cf30 (Metraipolis archive dc_dc248e81cf30, sha256 a329043f5c5b40ca1298e2b92322ec967a24e37fde4c1b8d18e5fb107ec6ea42)
BibTeX
@misc{dcdc248e81cf30,
  title = {Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis — Europe PMC PMID:41717337},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41717337},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc248e81cf30; sha256 a329043f5c5b40ca1298e2b92322ec967a24e37fde4c1b8d18e5fb107ec6ea42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41717337. Agents can read the archived copy with the MCP tool read_document.